Figure 1: The results of ex vivo studies evaluating the relationships between the prolongation of activated partial thromboplastin time, prothrombin time and factor V procoagulant activity (Hemosil Instrumentation Laboratory reagents) and the monoclonal immunoglobulin G concentration (protein M isolated from multiple myeloma patient’s blood) in the control plasma samples.